Segment Information - Schedule of Significant Expense Categories of the Company’s Single Operating Segment (Details) - USD ($) |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Schedule of Significant Revenue and Expense Categories of the Company’s Single Operating Segment [Abstract] | ||||||
| Clinical trial related service fee to related party (Note 5) | $ 1,375,000 | $ 4,625,000 | $ 2,750,000 | $ 6,000,000 | ||
| Consulting fee | 15,000 | 25,000 | 30,000 | 50,000 | ||
| Stock-based compensation (Note 8) | 145,298 | 159,098 | 292,012 | 318,193 | ||
| Salary expense | 131,272 | 131,096 | 260,036 | 260,807 | ||
| Professional fee | 289,932 | 475,437 | 688,065 | 760,527 | ||
| Insurance expense | 81,850 | 83,636 | 161,189 | 164,693 | ||
| Other general and administrative fee | 45,895 | 44,761 | 86,382 | 94,106 | ||
| Change in fair value of derivative liabilities | 222,092 | 330,719 | ||||
| Loss before income tax | 2,306,339 | 5,544,028 | 4,598,403 | 7,648,326 | ||
| Income tax expense | 850 | 863 | ||||
| Net loss | $ 2,306,339 | $ 2,292,064 | $ 5,544,878 | $ 2,104,311 | $ 4,598,403 | $ 7,649,189 |
| X | ||||||||||
- Definition Clinical trial related service fee, a related party. No definition available.
|
| X | ||||||||||
- Definition The amount of consulting fee. No definition available.
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The expense in the period incurred with respect to protection provided by insurance entities against risks other than risks associated with production (which are allocated to cost of sales). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|